Ntrk Gene Fusion-positive Cancers
📧 Sign up to get email alerts when something new happens for Ntrk Gene Fusion-positive Cancers.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-11-26FDA Approved: VITRAKVI — Original Application (Loxo Oncology, Inc.)
The FDA granted original approval of VITRAKVI (larotrectinib) as a tissue-agnostic treatment for cancers with an NTRK gene fusion, marking i…